South Wales, Nov. 21 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "EvidenceRx" on Nov. 6. The details about the trademark application no. UK00004290483 published in the journal no. 2025/047 (Nov. 21).
Consilium Scientific filed the trademark application for the below mentioned good(s)/service(s).
Class 42 : Software as a service [SaaS] featuring computer software platforms for artificial intelligence; Software as a service [SaaS] featuring software for machine learning; Platform as a Service [PaaS]; Hosting platforms on the Internet; Platforms for artificial intelligence as software as a service [SaaS]; Providing temporary use of non-downloadable software applications accessible via a web site.
Class 44 : Advisory services relating to health care; Information services relating to health care; Provision of health information; Health advice and information services; Medical information.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004290483
Disclaimer: Curated by HT Syndication.
